DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Dobutamine Hydrochloride is a drug marketed by Baxter Hlthcare, Dr Reddys, Hospira, Luitpold, Teligent, Teva Parenteral, Watson Labs, Watson Labs Inc, and West-ward Pharms Int. and is included in fourteen NDAs.
The generic ingredient in DOBUTAMINE HYDROCHLORIDE is dobutamine hydrochloride. There are fourteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dobutamine hydrochloride profile page.
A generic version of DOBUTAMINE HYDROCHLORIDE was approved as dobutamine hydrochloride by HOSPIRA on November 29th, 1993.
Summary for DOBUTAMINE HYDROCHLORIDE
|Finished Product Suppliers / Packagers:||2|
|Raw Ingredient (Bulk) Api Vendors:||89|
|Formulation / Manufacturing:||see details|
|What excipients (inactive ingredients) are in DOBUTAMINE HYDROCHLORIDE?||DOBUTAMINE HYDROCHLORIDE excipients list|
|DailyMed Link:||DOBUTAMINE HYDROCHLORIDE at DailyMed|
Recent Clinical Trials for DOBUTAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Institute of Liver and Biliary Sciences, India||N/A|
|Assistance Publique - Hôpitaux de Paris||Phase 3|
|Centre d’Investigation Clinique 1415||Phase 3|